Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Nuclear receptor ROR-gamma | ||
Ligand | BDBM362868 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Binding Assay | ||
Ki | <100±n/a nM | ||
Citation | Claremon, DA; Dillard, LW; Dong, C; Fan, Y; Jia, L; Lotesta, SD; Marcus, A; Singh, SB; Tice, CM; Yuan, J; Zhao, W; Zheng, Y; Zhuang, L Isoindoline inhibitors of ROR-gamma US Patent US9845308 Publication Date 12/19/2017 | ||
More Info.: | Get all data from this article, Assay Method | ||
Nuclear receptor ROR-gamma | |||
Name: | Nuclear receptor ROR-gamma | ||
Synonyms: | NR1F3 | Nuclear receptor ROR-gamma | Nuclear receptor ROR-gamma (RORC) | Nuclear receptor subfamily 1 group F member 3 | RAR-related orphan receptor C (RORc) | RORC | RORG | RORG_HUMAN | RZRG | Retinoid-related orphan receptor-gamma | Retinoid-related orphan receptor-gamma (RORc) | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 58218.40 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P51449 | ||
Residue: | 518 | ||
Sequence: |
| ||
BDBM362868 | |||
n/a | |||
Name | BDBM362868 | ||
Synonyms: | US9845308, Example 4a | US9845308, Example 5a | ||
Type | Small organic molecule | ||
Emp. Form. | C27H40F3N3O3S | ||
Mol. Mass. | 543.685 | ||
SMILES | CC(C)[C@@H]1N(C[C@H]2CC[C@@H](CC2)C(F)(F)F)Cc2cc(ccc12)C(=O)NCC1CCN(CC1)S(C)(=O)=O |r,wU:9.12,wD:6.5,3.2,(-6.52,-3.89,;-5.04,-3.49,;-3.95,-4.58,;-4.64,-2,;-5.54,-.76,;-7.08,-.76,;-7.85,.58,;-7.08,1.91,;-7.85,3.24,;-9.39,3.24,;-10.16,1.91,;-9.39,.58,;-10.16,4.58,;-9.39,5.91,;-11.7,4.58,;-10.93,5.91,;-4.64,.49,;-3.17,.01,;-1.84,.78,;-.51,.01,;-.51,-1.53,;-1.84,-2.3,;-3.17,-1.53,;.83,.78,;.83,2.32,;2.16,.01,;3.49,.78,;4.83,.01,;4.83,-1.53,;6.16,-2.3,;7.54,-1.55,;7.5,.01,;6.16,.78,;8.88,-2.32,;9.65,-.99,;10.21,-3.09,;8.11,-3.66,)| | ||
Structure |